Consolidated Balance Sheets - USD ($) $ in Millions	Sep. 30, 2018	Mar. 31, 2018
ASSETS
Cash and cash equivalents	$ 5,740	$ 3,540
Restricted cash and cash equivalents	991	1,219
Investments in marketable securities	4,603	5,829
Finance receivables, net	69,328	69,647
Investments in operating leases, net	38,883	38,697
Other assets	1,515	1,614
Total assets	121,060	120,546
LIABILITIES AND SHAREHOLDER’S EQUITY
Debt	98,228	98,353
Deferred income taxes	5,373	5,326
Other liabilities	4,405	3,987
Total liabilities	108,006	107,666
Commitments and contingencies (Refer to Note 11)
Shareholder’s equity:
Capital stock, no par value (100,000 shares authorized; 91,500 issued and outstanding) at September 30, 2018 and March 31, 2018	915	915
Additional paid-in capital	2	2
Accumulated other comprehensive loss	(19)	(29)
Retained earnings	12,156	11,992
Total shareholder's equity	13,054	12,880
Total liabilities and shareholder's equity	$ 121,060	$ 120,546